Oximio in the Middle East

Through our GMP facility in Israel, GDP Depot in Turkey and audited local Depot Partners in Egypt and Lebanon we provide access to 207 million patients of Middle East. With Oximio broad range of services and deep expertise, we are ready to tailor a supply strategy to fit your trial requirements.

Our Service Coverage in the Middle East:

Oximio Middle East
Egypt
Lebanon

Oximio Locations

Europe

Georgia

Hungary

Russia

Serbia

Ukraine

Partner Depot Belarus

Partner Depot Moldova

Middle East

Israel

Turkey

Partner Depot Lebanon

Partner Depot Egypt

Africa

South Africa

Partner Depot Kenya

Asia
Partner Depot India

Our Supply Chain Management team is ready to assist in defining optimal distribution strategy and support the needs of your next clinical study.